Review of Bharat Biotech's Covid-19 vaccine Covaxin is underway: WHO
Recommendation within next 24 hours if everything goes well, says Margaret Harris.
- Oct 26, 2021,
- Updated Oct 26, 2021 7:19 PM IST
A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said. "If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing. Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.
Also Read: COVID-19: Moderna says its vaccine safe for 6-11 years old children
Also Read: Over 107 crore Covid-19 vaccine doses provided to States, UTs: Centre
A World Health Organization technical advisory group was reviewing data on India's Covaxin shot against COVID-19 on Tuesday with a decision on its emergency use listing likely soon, a spokesperson said. "If all is in place and all goes well and if the committee is satisfied, we would expect a recommendation within the next 24 hours or so," Margaret Harris told journalists at a U.N. press briefing. Millions of Indians have taken the shot produced by Bharat Biotech but many have been unable to travel pending the WHO approval.
Also Read: COVID-19: Moderna says its vaccine safe for 6-11 years old children
Also Read: Over 107 crore Covid-19 vaccine doses provided to States, UTs: Centre